Yang, Hong

The Human Pathology Atlas for deciphering the prognostic features of human cancers

A human pan-disease blood atlas of the circulating proteome

Targeting PKLR in liver diseases

Anticancer effects and mechanisms of Pulsatilla chinensis, Bupleurum chinense and Polyporus umbellatus on human lung carcinoma and hepatoma cells

Integrative proteo-transcriptomic characterization of advanced fibrosis in chronic liver disease across etiologies

Multi-tissue network analysis reveals the effect of JNK inhibition on dietary sucrose-induced metabolic dysfunction in rats

Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial

Identification of <i>SPP1</i><SUP>+</SUP> macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning ( vol 83 , 104214 , 2022)

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases (Retraction of Vol 314, art no 121325, 2023)

Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases

Characterization of an <i>in vitro</i> steatosis model simulating activated <i>de novo</i> lipogenesis in MAFLD patients

Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation

The acute effect of different NAD plus precursors included in the combined metabolic activators

Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators

Revisiting the role of serine metabolism in hepatic lipogenesis

Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Discovery of therapeutic agents targeting <i>PKLR </i>for <i>NAFLD </i>using drug repositioning

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach

Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis

A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic liver disease

Combined Metabolic Activators Decrease Liver Steatosis by Activating Mitochondrial Metabolism in Hamsters Fed with a High-Fat Diet

Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19